` Comparison: SYRE, ABBV - Alpha Spread

SYRE
vs
ABBV

Over the past 12 months, SYRE has underperformed ABBV, delivering a return of -50% compared to the ABBV's +16% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
SYRE
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

SYRE Intrinsic Value
9.98 USD
Overvaluation 33%
Intrinsic Value
Price
ABBV Intrinsic Value
197.06 USD
Overvaluation 11%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Spyre Therapeutics Inc
NASDAQ:SYRE
14.88 USD
Abbvie Inc
NYSE:ABBV
222.47 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
SYRE, ABBV

SYRE
ABBV
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Spyre Therapeutics Inc
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
SYRE, ABBV

SYRE
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Spyre Therapeutics Inc
NASDAQ:SYRE
Abbvie Inc
NYSE:ABBV
What is Free Cash Flow?

Gross Margin

SYRE
0%
ABBV
70.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Spyre Therapeutics Inc
Abbvie Inc

Operating Margin

SYRE
0%
ABBV
31.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Spyre Therapeutics Inc
Abbvie Inc

Net Margin

SYRE
0%
ABBV
6.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Spyre Therapeutics Inc
Abbvie Inc

FCF Margin

SYRE
0%
ABBV
31.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Spyre Therapeutics Inc
Abbvie Inc

ROE

SYRE
-52.9%
ABBV
112.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Spyre Therapeutics Inc
Abbvie Inc

ROA

SYRE
-43.8%
ABBV
2.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Spyre Therapeutics Inc
Abbvie Inc

ROIC

SYRE
3 873.5%
ABBV
22.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Spyre Therapeutics Inc
Abbvie Inc

ROCE

SYRE
-48.3%
ABBV
18.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Spyre Therapeutics Inc
Abbvie Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
SYRE, ABBV

Loading

Performance Gap
SYRE, ABBV

Loading
SYRE
ABBV
Difference
www.alphaspread.com

Performance By Year
SYRE, ABBV

Loading
SYRE
ABBV
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare SYRE to other stocks
Unlock Full Access to Alpha Spread
Create Free Account